We are live on ! Find out more
TC

Tejara Capital Portfolio holdings

AUM $243M
1-Year Est. Return 9.84%
This Fund
S&P 500
This Quarter Est. Return
+14.5%
1 Year Est. Return
+9.84%
3 Year Est. Return
+17.31%
5 Year Est. Return
10 Year Est. Return
AUM
$272M
AUM Growth
+$33.4M
Cap. Flow
+$10.3M
Cap. Flow %
3.79%
Top 10 Hldgs %
48.68%
Holding
93
New
26
Increased
22
Reduced
22
Closed
18

Top Sells

Rank Stock Value
1
NEM icon
Newmont
NEM
+$9.57M
2
C icon
Citigroup
C
+$7.9M
3
FCX icon
Freeport-McMoran
FCX
+$5.18M
4
COLL icon
Collegium Pharmaceutical
COLL
+$4.34M
5
MREO
Mereo BioPharma
MREO
+$4.21M

Sector Composition

Rank Sector Weight
1 Healthcare 37.56%
2 Energy 35.34%
3 Technology 5.46%
4 Industrials 4.42%
5 Miscellaneous 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROIV icon
1
Roivant Sciences
ROIV
$25.1B
$27.4M 10.07%
2,600,295
+465,400
+22% +$5.02M
STNG icon
2
Scorpio Tankers
STNG
$3.91B
$23.2M 8.54%
324,700
+173,979
+115% +$11.8M
HRTX icon
3
Heron Therapeutics
HRTX
$62M
$12.2M 4.49%
4,411,567
-863,669
-16% -$2.17M
GLNG icon
4
Golar LNG
GLNG
$5.13B
$12M 4.41%
498,701
-9,579
-2% -$213K
NBR icon
5
Nabors Industries
NBR
$1.39B
$11.1M 4.06%
128,437
-4,488
-3% -$367K
TEVA icon
6
Teva Pharmaceuticals
TEVA
$42.5B
$11M 4.05%
780,206
-275,800
-26% -$3.48M
ARQT icon
7
Arcutis Biotherapeutics
ARQT
$2.99B
$9.32M 3.42%
940,487
-171,730
-15% -$1.28M
NOV icon
8
NOV
NOV
$7.48B
$9.21M 3.39%
471,965
+70,900
+18% +$1.32M
BORR
9
Borr Drilling
BORR
$1.37B
$8.86M 3.26%
1,293,193
+32,000
+3% +$210K
MREO
10
Mereo BioPharma
MREO
$40.3M
$8.15M 3%
2,470,184
-1,242,945
-33% -$4.21M
LBTYA icon
11
Liberty Global Class A
LBTYA
$3.64B
$7.82M 2.87%
462,170
-67,330
-13% -$1.23M
REKR icon
12
Rekor Systems
REKR
$75.5M
$7.52M 2.76%
3,285,476
+1,828,887
+126% +$5.04M
RIG icon
13
Transocean
RIG
$6.48B
$7.25M 2.67%
1,155,100
+540,100
+88% +$2.95M
BGC icon
14
BGC Group
BGC
$5.76B
$6.54M 2.4%
841,456
+25,384
+3% +$188K
OFIX icon
15
Orthofix Medical
OFIX
$395M
$6.31M 2.32%
434,711
+40,616
+10% +$562K
VTRS icon
16
Viatris
VTRS
$18.8B
$6M 2.2%
502,515
-110,300
-18% -$1.33M
GEO icon
17
The GEO Group
GEO
$4.25B
$5.2M 1.91%
367,936
-195,308
-35% -$2.33M
NE icon
18
Noble Corp
NE
$7.31B
$4.39M 1.61%
90,445
+10,000
+12% +$450K
FET icon
19
Forum Energy Technologies
FET
$907M
$4.26M 1.57%
213,434
+4,344
+2% +$85.7K
BTU icon
20
Peabody Energy
BTU
$3.53B
$4.14M 1.52%
170,747
+19,480
+13% +$490K
NXE icon
21
NexGen Energy
NXE
$6.97B
$3.86M 1.42%
496,150
+208,350
+72% +$1.55M
GDXJ icon
22
VanEck Junior Gold Miners ETF
GDXJ
$9.48B
$3.75M 1.38%
96,900
+20,000
+26% +$691K
SCPH
23
DELISTED
scPharmaceuticals
SCPH
$3.5M 1.29%
698,186
-59,585
-8% -$334K
SSYS icon
24
Stratasys
SSYS
$678M
$3.45M 1.27%
296,633
+217,318
+274% +$2.79M
SLV icon
25
iShares Silver Trust
SLV
$32.3B
$3.41M 1.25%
+150,000
New +$3.2M

Similar funds

Tejara Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Tejara Capital held 93 positions worth $272M, up 14% from $239M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Tejara Capital deployed $10.3M of net new capital in Q1 2024, opening 26 new positions and adding to 22 existing holdings. Its largest new stake was QuidelOrtho: 70,000 shares worth $3.36M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 38% a quarter earlier, followed by Energy and Technology.

On the sell side, the largest reduction was Mereo BioPharma, an estimated $4.21M trimmed.

  • Tejara Capital's largest Q1 2024 buy was QuidelOrtho: 70,000 shares worth $3.36M.
  • Tejara Capital added most to Scorpio Tankers in Q1 2024, an estimated $11.8M increase.
  • Tejara Capital's biggest Q1 2024 reduction was Mereo BioPharma, cutting an estimated $4.21M.
  • Tejara Capital fully exited Newmont in Q1 2024, selling an estimated $9.57M.
  • Tejara Capital's ten largest holdings make up 49% of its $272M portfolio in Q1 2024.
  • Tejara Capital opened 26 new positions and closed 18 in Q1 2024.
  • Tejara Capital's portfolio value rose 14% quarter-over-quarter to $272M.

Based on Tejara Capital's 13F filing for Q1 2024, filed 14 May 2024.